Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Sep 24, 2010


Vermillion has appointed Jeffrey Salzman as corporate director of reimbursement. Salzman previously was director of health plans and payor markets at Ipsogen and he worked for nine years at Quest Diagnostics as an executive in health planning.

Salzman will be responsible for expanding reimbursement for the company's OVA1 test, which launched in March and is being marketed by Quest.

"My priority will be to leverage my years of experience within the payor community as well as interfacing with Quest Diagnostics to build upon the coverage momentum currently underway," Salzman said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.